Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06754176 · ClinicalTrials.gov registry record · NA
Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation
A NA study of Atrial Fibrillation (AF) and Atrial Fibrillation Paroxysmal, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT06754176: Recruiting NA study of Atrial Fibrillation (AF) and Atrial Fibrillation Paroxysmal, sponsored by University of California, San Francisco.
NCT06754176 is a NA study of Atrial Fibrillation (AF) and Atrial Fibrillation Paroxysmal that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 714-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06754176, a NA study of Atrial Fibrillation (AF) and Atrial Fibrillation Paroxysmal, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to assess the short-term effects of minimal and moderate drinking on atrial fibrillation (AFib) episodes in a real-world population diagnosed with 'come-and-go'/paroxysmal AFib. The question it aims to answer is: Is there a greater occurrence of AFib episodes when participants are allowed to consume alcohol according to random assignment? Participants will: * Be given daily random assignments to avoid or not to avoid alcohol * Wear an adhesive electrocardiographic (ECG) heart monitor * Wear a wrist-worn fitness tracker * Wear an anklet transdermal alcohol monitor * Wear an adhesive glucose monitor * Complete morning and evening surveys daily Participants may be compensated up to $50 for full completion of the study. This study can be done in-person or remote.
Primary Outcome
Participants will be wearing a continuously recording ECG monitor for two weeks. The primary outcome will be the presence (versus absence) of at least one AFib episode on randomly assigned drinking versus non-drinking days.
Conditions Studied
Interventions
- BEHAVIORAL Alcohol Consumption Randomized Instructions
Study Locations (2)
California
- UCSF Medical Center at Parnassus - San Francisco
- UCSF Medical Center at Mission Bay - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-04-17 |
| Est. Completion | 2029-08 |
| Phase | NA |
What NCT06754176 shows while recruiting
NCT06754176 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 714-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Atrial Fibrillation (AF) appearing as the primary indexed condition, and to 1 intervention - of which Alcohol Consumption Randomized Instructions is the first listed.
NCT06754176 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06754176 about?
NCT06754176 is a clinical study titled "Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation". The goal of this study is to assess the short-term effects of minimal and moderate drinking on atrial fibrillation (AFib) episodes in a real-world population diagnosed with 'come-and-go'/paroxysmal AFib. The question it aims to answer is: Is there a greater occurrence of AFib episodes when particip...
What is the current status of trial NCT06754176?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-04-17. Estimated completion is 2029-08.
What conditions does trial NCT06754176 study?
This clinical trial studies the following conditions: Atrial Fibrillation (AF), Atrial Fibrillation Paroxysmal.
What interventions are being tested in trial NCT06754176?
The interventions under investigation include: Alcohol Consumption Randomized Instructions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06754176?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06754176 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation (AF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06754176's enrollment target sits among peer trials
100 16th of 17 the lowest of 17 other Atrial Fibrillation (AF) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation (AF) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity
RECRUITING · NA
-
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
RECRUITING · NA
-
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
RECRUITING · NA
-
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
RECRUITING · NA
-
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
RECRUITING · NA
-
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI